SG

Symbiosis Group

Description

Symbiosis Group Limited is an investment company building a portfolio of innovative life science companies.

Investor Profile

Symbiosis Group has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (25%)
  • Series Unknown (25%)
  • Series D (25%)
  • Series C (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Agriculture
  • Agtech
  • Health Care
  • Clinical Trials
  • Machine Learning
  • Therapeutics
  • Business Development
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Symbiosis Group frequently co-invest with?

Fall Line Capital
North America, California, United States, San Mateo
Co-Investments: 1
Shumway Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
FF
North America, California, United States, San Francisco
Co-Investments: 1
Insud Pharma
Europe, Madrid, Spain, Madrid
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CF
North America, Massachusetts, United States, Woburn
Co-Investments: 1
RC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Continental Grain Company
North America, New York, United States, New York
Co-Investments: 1
BNP Paribas Asset Management
North America, Idaho, United States, France
Co-Investments: 1

What are some of recent deals done by Symbiosis Group?

Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Post Ipo EquityAug 12, 2022
Amount Raised: $109,000,000
Biosplice Therapeutics

San Diego, California, United States

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.

BiotechnologyHealth CareLife Science
Series UnknownApr 15, 2021
Amount Raised: $120,000,000
Finch Therapeutics

Somerville, Massachusetts, United States

Finch Therapeutics is a microbiome development company that serve patients with serious unmet medical needs.

BiotechnologyClinical TrialsMachine LearningTherapeutics
Series DSep 17, 2020
Amount Raised: $90,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series CMay 13, 2019
Amount Raised: $18,500,000